Ian Karp
Head of Investor Relations
Replay available
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) Q4 2025 earnings conference call, held 2026-02-26. Replay captured from the company's public earnings webcast.

Head of Investor Relations
President and Chief Executive Officer
Chief Commercial Officer
Chief Financial Officer
Analyst, Truist Securities
Analyst, H.C. Wainwright & Co.
Analyst, Piper Sandler & Co.
Watch the replay and follow the connected company analysis, news, and investor updates for Collegium Pharmaceutical, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.217 Greetings. Welcome to the Collegium Pharmaceutical fourth quarter and full year 2025 00:00:04.217 -- 00:00:08.844 earnings conference call. At this time, all participants are in listen-only mode. 00:00:08.844 -- 00:00:12.570 A question and answer session will follow the formal presentation. 00:00:12.570 -- 00:00:16.175 If anyone should require operator assistance during this conference call, please press 00:00:16.175 -- 00:00:18.999 star zero on your telephone keypad. 00:00:18.999 -- 00:00:21.823 Please note this conference call is being recorded. 00:00:21.823 -- 00:00:25.729 I'll now turn the call over to Ian Karp, Head of Investor Relations at Collegium. 00:00:25.729 -- 00:00:28.553 Thank you. You may now begin. 00:00:28.553 -- 00:00:29.528 Great. Thanks. 00:00:29.528 -- 00:00:34.253 Welcome to Collegium Pharmaceuticals' fourth quarter and full year 2025 earnings conference 00:00:34.253 -- 00:00:38.918 call. I'm joined today by Vikram Karnani, our President and Chief Executive Officer, 00:00:38.918 -- 00:00:44.264 Colleen Tupper, our Chief Financial Officer, and Scott Dreyer, our Chief Commercial Officer. 00:00:44.264 -- 00:00:47.968 Before we begin today's call, we want to remind participants that none of the information 00:00:47.968 -- 00:00:51.711 presented today is intended to be promotional and that any forward-looking statements 00:00:51.711 -- 00:00:56.236 made today are made pursuant to the safe harbor provision of the Private Security Litigation 00:00:56.236 -- 00:01:00.760 Reform Act of 1995. We are cautioned that such forward-looking statements involve risks 00:01:00.760 -- 00:01:05.943 and uncertainties as detailed in the company's periodic reports 00:01:06.526 -- 00:01:08.808 filed with the Securities and Exchange Co...